Mirae Asset Global Investments’s NewAmsterdam Pharma NAMS Stock Holding History

Mirae Asset Global Investments’s Portfolio NAMS Stock Details NAMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$177K	Sell	5,228 -769	-13%	-$25.3K	﹤0.01%	1142
2026 Q1	$192K	Buy	5,997 +487	+9%	+$15.9K	﹤0.01%	1075
2025 Q4	$193K	Buy	5,510 +1,156	+27%	+$42.1K	﹤0.01%	1149
2025 Q3	$124K	Buy	4,354 +17	+0.4%	+$408	﹤0.01%	1177
2025 Q2	$78.5K	Buy	4,337 +662	+18%	+$12.1K	﹤0.01%	1178
2025 Q1	$80K	Buy	3,675 +596	+19%	+$13.2K	﹤0.01%	1153
2024 Q4	$79.6K	Buy	+3,079	New	+$65.4K	﹤0.01%	1190

Other funds holding NAMS

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Mirae Asset Global Investments's NAMS Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its NewAmsterdam Pharma (NAMS) stake by 13% in Q2 2026, selling an estimated $25.3K and leaving 5,228 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Mirae Asset Global Investments first reported a position in NAMS in Q4 2024 and has held it in 7 quarters since. The position peaked at $193K in Q4 2025. 66 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

Mirae Asset Global Investments held 5,228 shares of NewAmsterdam Pharma worth $177K as of Q2 2026.
Mirae Asset Global Investments sold 769 NewAmsterdam Pharma shares in Q2 2026, an estimated $25.3K.
NewAmsterdam Pharma made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1142 holding.
Mirae Asset Global Investments first reported a position in NewAmsterdam Pharma in Q4 2024 and has held it in 7 quarters since.
Mirae Asset Global Investments's NewAmsterdam Pharma position peaked at $193K in Q4 2025.
66 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.